News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Preclinical Studies Suggest That Living Cell Technologies Ltd.'s NeurotrophinCell is Effective in Parkinson’s Disease



12/11/2008 10:08:30 AM

MELBOURNE, Australia & AUCKLAND, New Zealand & BOULDER, Colo.--(BUSINESS WIRE)--Living Cell Technologies Limited (ASX: LCT; OTCQX: LVCLY) today reported that its pipeline product, NeurotrophinCell (NtCell), encapsulated brain choroid plexus cells, may be beneficial in Parkinson’s disease.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES